Healy BC - Search Results

1

Progression rates and sample size estimates for PPMS based on the CLIMB study population.

Raghavan K, Healy BC, Carruthers RL, Chitnis T. Raghavan K, et al. Among authors: healy bc. Mult Scler. 2015 Feb;21(2):180-8. doi: 10.1177/1352458514541976. Epub 2014 Jul 28. Mult Scler. 2015. PMID: 25070676

2

Unbiased treatment effect estimates by modeling the disease process of multiple sclerosis.

Healy BC, Hayden DL, Sampat MP, Bakshi R, Guttmann CR. Healy BC, et al. J Neurol Sci. 2009 Mar 15;278(1-2):54-9. doi: 10.1016/j.jns.2008.11.013. Epub 2009 Jan 1. J Neurol Sci. 2009. PMID: 19121526

3

Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.

Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Gorman MP, et al. Among authors: healy bc. Arch Neurol. 2009 Jan;66(1):54-9. doi: 10.1001/archneurol.2008.505. Arch Neurol. 2009. PMID: 19139299

4

Smoking and disease progression in multiple sclerosis.

Healy BC, Ali EN, Guttmann CR, Chitnis T, Glanz BI, Buckle G, Houtchens M, Stazzone L, Moodie J, Berger AM, Duan Y, Bakshi R, Khoury S, Weiner H, Ascherio A. Healy BC, et al. Arch Neurol. 2009 Jul;66(7):858-64. doi: 10.1001/archneurol.2009.122. Arch Neurol. 2009. PMID: 19597087 Free PMC article.

5

Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint.

Healy BC, Ikle D, Macklin EA, Cutter G. Healy BC, et al. Mult Scler. 2010 Jul;16(7):840-7. doi: 10.1177/1352458510371409. Epub 2010 Jun 7. Mult Scler. 2010. PMID: 20530124

6

A method for evaluating treatment switching criteria in multiple sclerosis.

Healy BC, Glanz BI, Stankiewicz J, Buckle G, Weiner H, Chitnis T. Healy BC, et al. Mult Scler. 2010 Dec;16(12):1483-9. doi: 10.1177/1352458510379245. Epub 2010 Aug 24. Mult Scler. 2010. PMID: 20736245

7

Population structure and HLA DRB1 1501 in the response of subjects with multiple sclerosis to first-line treatments.

Gross R, Healy BC, Cepok S, Chitnis T, Khoury SJ, Hemmer B, Weiner HL, Hafler DA, De Jager PL. Gross R, et al. Among authors: healy bc. J Neuroimmunol. 2011 Apr;233(1-2):168-74. doi: 10.1016/j.jneuroim.2010.10.038. Epub 2010 Nov 27. J Neuroimmunol. 2011. PMID: 21115201

8

Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis.

Healy BC, Engler D, Gholipour T, Weiner H, Bakshi R, Chitnis T. Healy BC, et al. J Neurol Sci. 2011 Apr 15;303(1-2):109-13. doi: 10.1016/j.jns.2010.12.024. Epub 2011 Jan 19. J Neurol Sci. 2011. PMID: 21251671

9

Patient reported outcomes in benign multiple sclerosis.

Hviid LE, Healy BC, Rintell DJ, Chitnis T, Weiner HL, Glanz BI. Hviid LE, et al. Among authors: healy bc. Mult Scler. 2011 Jul;17(7):876-84. doi: 10.1177/1352458511398370. Epub 2011 Mar 3. Mult Scler. 2011. PMID: 21372114

10

One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis.

Liguori M, Meier DS, Hildenbrand P, Healy BC, Chitnis T, Baruch NF, Khoury SJ, Weiner HL, Bakshi R, Barkhof F, Guttmann CR. Liguori M, et al. Among authors: healy bc. J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1125-31. doi: 10.1136/jnnp.2011.242115. Epub 2011 Mar 22. J Neurol Neurosurg Psychiatry. 2011. PMID: 21429902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters